Global E Online Ltd vs Roivant Sciences Ltd. Common Shares — how do they compare? Global E Online Ltd trades at $40.37 (market cap $6.75B), while Roivant Sciences Ltd. Common Shares trades at $35.44 (market cap $24.72B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 3.7× Global E Online Ltd's market cap, and Global E Online Ltd is trading nearer its 52-week high, Roivant Sciences Ltd. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Global E Online Ltd for 21 Days and Roivant Sciences Ltd. Common Shares for 1 Days on average.
| GLBE | ROIV | |
|---|---|---|
Market Cap | $6.75B | $24.72B |
Volume | 1,468,708 | 6,279,442 |
Sector | Consumer Cyclical | Health |
52-Week High | $42.36 | $41.81 |
52-Week Low | $27.54 | $16.04 |
Typical Hold Time | 21 Days | 1 Days |
Enterprise Value | $6.24B | $20.99B |
Signals from Pluang's Aura AI — not financial advice
GLBE trades at $40.25, up 3.31% today, with a bullish technical signal from moving averages and strong analyst consensus. The company reported robust Q2 2026 earnings, beating EPS estimates and raising full-year guidance, with revenue growth of 39% year-over-year. Recent news includes the appointment of a new Chief Revenue Officer and significant insider selling by executives.
The outlook is positive, supported by strong revenue growth, expanding margins, and a high analyst buy rating. Key risks include elevated valuation multiples, insider selling pressure, and dependence on e-commerce market conditions. The stock offers potential upside to the consensus price target of $48.86.
No Aura AI signal available yet.
Trailing returns across standard periods
Global-e provides a platform for cross-border e-commerce, helping retailers increase international sales by localizing the shopping experience for consumers in over 200 destinations worldwide.
Read more on GLBE →Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →